Top 22 Pharmaceutical Manufacturing Companies in Puerto Rico
Top 22 Pharmaceutical Manufacturing Companies in Puerto Rico
Puerto Rico has established itself as a thriving hub for pharmaceutical manufacturing. The island is home to a mix of companies focusing on producing generic and branded medications, including therapies for chronic diseases, biosimilars, and active pharmaceutical ingredients (APIs). With high-quality standards and a regulatory-friendly environment, the industry attracts significant investments and research efforts. In recent years, businesses have increasingly turned towards biologics and personalized medicine, reflecting global healthcare trends. As demand continues to grow, the sector is set to play an even more pivotal role in the evolving pharmaceutical landscape.
This list highlights 22 pharmaceutical manufacturing companies primarily located in Puerto Rico, with headquarters spanning regions like India, Argentina, and the UK. Each company features distinct specializations, from generic medications to advanced biologics, and varies in size from small family-owned firms to corporate multinationals. Founded between 1934 and 2013, they demonstrate a commitment to innovation and quality across their offerings.
Read on to discover more about the top pharmaceutical manufacturing companies in Puerto Rico.
Top 22 Pharmaceutical Manufacturing Companies in Puerto Rico
1. Intas Pharmaceuticals
- Website: intaspharma.com
- Ownership type: Private Equity
- Headquarters: Ahmedabad, Gujarat, India
- Employee distribution: India 99%, Other 1%
- Latest funding: October 2022
- Founded year: 2000
- Headcount: 10001+
- LinkedIn: intas-biopharmaceuticals
Intas Pharmaceuticals Limited, based in Ahmedabad, Gujarat, India, is a private equity-owned pharmaceutical company that specializes in the development, manufacturing, and marketing of generic therapeutic drugs. Founded in 2000, Intas has grown to employ over 17,000 people, with a workforce primarily based in India. The company operates in more than 85 countries, focusing on international markets, particularly in the EU and the US, where it generates around 70% of its revenue. Intas is committed to addressing unmet medical needs through innovative products and a strong emphasis on quality. Their extensive product portfolio includes a range of formulations, from tablets to injectables, and they have made significant investments in research and development, with over 550 scientists working on new therapies. Intas is also recognized for its advancements in biosimilars and has established facilities that comply with global regulatory standards, including those set by the USFDA and EMA.
2. Laboratorios Bagó
- Website: bago.com.ar
- Ownership type: Private
- Headquarters: General Pacheco, Buenos Aires, Argentina
- Employee distribution: Argentina 70%, Brazil 6%, Ecuador 4%, Other 19%
- Founded year: 1934
- Headcount: 5001-10000
- LinkedIn: laboratorios_bago
Laboratorios Bagó is a prominent pharmaceutical company based in General Pacheco, Buenos Aires, Argentina. Founded in 1934 by Sebastián Bagó, the company has grown significantly over the decades, becoming a key player in the pharmaceutical industry. It specializes in the development and manufacturing of a wide range of prescription and over-the-counter medications. With a strong emphasis on research and development, Laboratorios Bagó has achieved notable milestones, including the creation of original molecules and innovative drug formulations. The company operates in over 50 countries, providing effective healthcare solutions and improving health outcomes for patients. Its commitment to quality and excellence is reflected in its rigorous adherence to international standards and its extensive portfolio of products. Laboratorios Bagó also engages in various initiatives aimed at enhancing medical education and supporting healthcare professionals, further solidifying its role in the pharmaceutical landscape.
3. Eskayef Pharmaceuticals Ltd.
- Website: skfbd.com
- Ownership type: Private
- Headquarters: Dhaka, Dhaka, Bangladesh
- Employee distribution: Bangladesh 100%
- Founded year: 1990
- Headcount: 5001-10000
- LinkedIn: eskayef-pharmaceuticals-limited
Eskayef Pharmaceuticals Ltd. is a private pharmaceutical company based in Dhaka, Bangladesh, founded in 1990. It specializes in the manufacture and marketing of therapeutic drugs and health products. The company serves healthcare providers and patients by offering a range of high-quality medications, including treatments for COVID-19. Eskayef operates globally, exporting to over 70 countries, which highlights its international presence and commitment to meeting global health needs. The company has made significant strides in its production capabilities, with multiple facilities accredited by stringent regulatory authorities such as the US FDA and UK MHRA. Eskayef is also involved in research and development, focusing on innovative medicines and vaccines. Its dedication to quality and ethical practices is evident in its operational philosophy, which aims to serve humanity with superior and affordable medicines.
4. Polpharma
- Website: polpharma.pl
- Ownership type: Private
- Headquarters: Poland
- Employee distribution: Poland 92%, Ukraine 2%, Other 6%
- Founded year: 1935
- Headcount: 1001-5000
- LinkedIn: polpharma
Polpharma is a prominent pharmaceutical company based in Poland, founded in 1935. With a workforce of over 4,300 employees, Polpharma specializes in the production of a wide array of medicines and healthcare solutions. The company is recognized as the largest Polish manufacturer of pharmaceuticals, actively operating in markets across Central and Eastern Europe, the Caucasus, and Central Asia. Polpharma is dedicated to innovation, investing significantly in research and development to create safe and effective products for patients, healthcare providers, and hospitals. Their product portfolio includes prescription medications, over-the-counter drugs, dietary supplements, and veterinary medicines. Polpharma also emphasizes corporate social responsibility, aiming to contribute positively to public health and the environment. The company has established multiple production facilities and R&D centers, ensuring compliance with the highest manufacturing standards. Through strategic partnerships and a commitment to quality, Polpharma continues to play a vital role in the healthcare industry.
5. Mundipharma
- Website: mundipharma.com
- Ownership type: Corporate
- Headquarters: Cambridge, England, United Kingdom (UK)
- Employee distribution: United Kingdom (UK) 27%, United Arab Emirates 6%, Brazil 5%, Other 63%
- Latest funding: June 2023
- Founded year: 1952
- Headcount: 1001-5000
- LinkedIn: mundipharma
Mundipharma International Limited is a British multinational pharmaceutical company headquartered in Cambridge, England. Established in 1952, the company specializes in research-based drug development, focusing on innovative treatments for various health conditions, including pain management and oncology. Mundipharma's product offerings include a range of medications for pain relief, biosimilars, and therapies for respiratory and central nervous system disorders. The company operates in over 120 countries, emphasizing collaboration and partnerships to improve patient care. Recently, Mundipharma has shifted its focus towards its prescription portfolio, having sold its Consumer Health business to iNova Pharmaceuticals in early 2024. This strategic move allows the company to concentrate on its specialty care business and enhance its pain management offerings.
6. PharmEvo Private Limited
- Website: pharmevo.biz
- Ownership type: Private
- Headquarters: Karachi, Sindh, Pakistan
- Employee distribution: Pakistan 96%, Other 4%
- Founded year: 1999
- Headcount: 1001-5000
- LinkedIn: pharmevo-pvt--ltd
PharmEvo Private Limited, founded in 1999 and based in Karachi, Pakistan, is a pharmaceutical company dedicated to the development, manufacturing, and marketing of innovative healthcare products. With a workforce of approximately 1,910 employees, PharmEvo serves healthcare professionals, hospitals, and patients by providing high-quality medications and solutions. The company is committed to enhancing patient safety and health outcomes through rigorous research and development efforts. PharmEvo operates a state-of-the-art manufacturing facility that complies with best international practices, ensuring the production of reliable and effective pharmaceutical products. Additionally, the company has made strides in pharmacovigilance, monitoring and reporting risks associated with drug use, which underscores its dedication to patient safety. PharmEvo's initiatives, such as PHARMASSIST and various health awareness programs, further demonstrate its active role in the healthcare community, making it a significant contributor to the pharmaceutical landscape in Pakistan.
7. Opsonin Pharma Ltd
- Website: opsonin-pharma.com
- Ownership type: Private
- Headquarters: Dhaka, Dhaka, Bangladesh
- Employee distribution: Bangladesh 99%
- Founded year: 1956
- Headcount: 5001-10000
- LinkedIn: opsonin-pharma
Opsonin Pharma Ltd, based in Dhaka, Bangladesh, is a pharmaceutical company that develops, manufactures, and markets generic medicines for human use. Established in 1956, Opsonin has grown to become a significant player in the pharmaceutical sector, focusing on improving healthcare quality both locally and internationally. The company offers a wide range of products, including over 350 brands and more than 800 SKUs, catering to various therapeutic classes such as antibiotics, antiulcerants, and antidiabetics. Opsonin Pharma is also involved in agrovet products, which further diversifies its portfolio. The company has made substantial investments in modern manufacturing facilities designed to meet international regulatory standards, ensuring the production of high-quality medicines. Opsonin Pharma has been proactive in expanding its global presence, exporting to approximately 25 countries, including regions in Asia, Africa, and the Middle East. This commitment to quality and accessibility positions Opsonin Pharma as a notable entity in the pharmaceutical manufacturing industry.
8. Douglas Pharmaceuticals
- Website: douglas.co.nz
- Ownership type: Family Owned
- Headquarters: Auckland, Auckland, New Zealand
- Employee distribution: New Zealand 88%, Fiji Islands 10%, Other 2%
- Founded year: 1967
- Headcount: 501-1000
- LinkedIn: douglas-pharmaceuticals
Douglas Pharmaceuticals, founded in 1967, is a family-owned pharmaceutical company based in Auckland, New Zealand. The company specializes in the manufacture and distribution of prescription medicines, nutraceuticals, and consumer healthcare products. With a workforce of approximately 631 employees, Douglas Pharmaceuticals has established a strong presence in both the New Zealand and Fijian markets, while also exporting its products to 40 countries globally. The company prides itself on its commitment to high manufacturing standards and quality, ensuring that all products meet stringent regulatory requirements. Douglas Pharmaceuticals also engages in research and development, collaborating with innovative partners to create effective healthcare solutions. Additionally, the company provides contract manufacturing services, showcasing its capabilities in producing a wide range of pharmaceutical and nutraceutical products. Its focus on improving health outcomes through quality products and innovative solutions underscores its role in the pharmaceutical industry.
9. Amoun Pharmaceutical Company
- Website: amoun.com
- Ownership type: Corporate
- Headquarters: Al Waili Al Kabir Sharq, Cairo Governorate, Egypt
- Employee distribution: Egypt 97%, Other 3%
- Latest funding: $740.0M, March 2021
- Founded year: 1998
- Headcount: 1001-5000
- LinkedIn: amoun-pharmaceutical-industries-company
Amoun Pharmaceutical Company S.A.E. is an Egyptian joint-stock company established in 1998, headquartered in El Obour City, Egypt. The company specializes in the development, manufacturing, marketing, and distribution of pharmaceutical products. With a workforce of over 2,500 employees, Amoun operates one of the largest pharmaceutical manufacturing facilities in Africa and the Middle East, utilizing advanced technology to ensure product quality and safety. The company offers a wide range of pharmaceutical products, including tablets, capsules, and sterile solutions, catering to various therapeutic needs. Amoun has a strong commitment to research and development, continuously optimizing its manufacturing processes and expanding its product pipeline. In 2021, the company was acquired by Abu Dhabi Developmental Holding Company (ADQ), which has further enhanced its capabilities and resources in the healthcare sector. Amoun's sales have shown impressive growth, with a compounded annual growth rate of 18% over the past five years, reflecting its strong market position and operational efficiency.
10. Cadila Pharmaceuticals Limited
- Website: cadilapharma.com
- Ownership type: Corporate
- Headquarters: Ahmedabad, Gujarat, India
- Employee distribution: India 97%, Other 3%
- Latest funding: September 2021
- Founded year: 1951
- Headcount: 5001-10000
- LinkedIn: cadila-pharmaceuticals
Cadila Pharmaceuticals Limited, based in Ahmedabad, Gujarat, India, is a prominent pharmaceutical company that has been operational since 1951. With a workforce of over 8,300 employees, the company specializes in manufacturing a wide array of products, including active pharmaceutical intermediates, finished formulations, and biotechnology products. Cadila is dedicated to providing affordable and innovative medical solutions, aiming to improve health outcomes for patients globally. The company has a robust research and development framework, with a team of 350 scientists focused on addressing unmet medical needs. Cadila's manufacturing facilities comply with stringent international regulations, including those set by the USFDA and WHO. The company has a global outreach, serving healthcare providers and patients in over 85 countries, and is committed to ethical practices in clinical research and business operations.
11. Ems
- Website: ems.com.br
- Ownership type: Private
- Headquarters: Hortolândia, Sao Paulo, Brazil
- Employee distribution: Brazil 99%, Other 1%
- Latest funding: Other (Debt), $91.1M, August 2024
- Founded year: 1964
- Headcount: 1001-5000
- LinkedIn: ems
Ems, founded in 1964 and based in Hortolândia, São Paulo, Brazil, is a private pharmaceutical manufacturer that specializes in generic medications. With a workforce of over 12,000 employees, the company has carved out a significant position in the Brazilian pharmaceutical industry, achieving high sales volumes and units sold. Ems is committed to making healthcare accessible by offering a range of affordable medication options. The company actively engages with healthcare providers and consumers, ensuring that its products meet the needs of the market. Recently, Ems secured funding of approximately 91 million USD, indicating a strong financial backing for its operations and future initiatives.
12. Pharmasyntez Group of Companies
- Website: pharmasyntez.com
- Ownership type: Private
- Headquarters: Russia
- Employee distribution: Russia 96%, China 4%
- Founded year: 1997
- Headcount: 1001-5000
- LinkedIn: jsc-pharmasyntez
Pharmasyntez Group of Companies is a private pharmaceutical manufacturer based in Russia, founded in 1997. The company specializes in the development and production of medications targeting significant health challenges, including tuberculosis, HIV, oncology, diabetes, hepatitis, and COVID-19. With a workforce of over 4,000 skilled professionals, Pharmasyntez operates five manufacturing facilities located in various cities across Russia, including Irkutsk, Ussuriysk, Tyumen, Saint Petersburg, and Bratsk. The company is dedicated to ensuring that healthcare providers and patients have access to high-quality pharmaceuticals. Pharmasyntez actively seeks partnerships with both Russian and international pharmaceutical companies, aiming to enhance its product offerings and expand its market reach. Their focus on scientific research and development underpins their commitment to innovation in the pharmaceutical sector.
13. Martin Dow Limited
- Website: martindow.com
- Ownership type: Private
- Headquarters: Karachi, Sindh, Pakistan
- Employee distribution: Pakistan 98%, Other 2%
- Founded year: 1995
- Headcount: 1001-5000
- LinkedIn: martindowltd
Martin Dow Limited, established in 1995, is a prominent pharmaceutical company located in Karachi, Pakistan. The company specializes in the manufacturing of pharmaceuticals, medical diagnostics, and chemicals, catering to the needs of healthcare providers and consumers alike. With a workforce of over 1,500 employees, Martin Dow is dedicated to delivering high-quality health solutions aimed at enhancing patient care and health outcomes. The company has made significant strides in the industry, including the acquisition of Roche's facility in Pakistan and the brand licensing of global product lines from Hoffmann-La Roche, Switzerland. Additionally, Martin Dow has expanded its operations through the establishment of various group companies, such as Martin Dow Marker Ltd. and Martin Dow Specialities Pvt. Ltd. Their commitment to technological advancement and strategic partnerships further solidifies their position in the pharmaceutical sector.
14. Laboratorios Vargas, S.A.
- Website: laboratoriosvargas.com
- Ownership type: Family Owned
- Headquarters: Caracas, Capital, Venezuela
- Employee distribution: Venezuela 98%, Peru 2%
- Founded year: 1955
- Headcount: 1001-5000
- LinkedIn: laboratorios-vargas-s.a.
Laboratorios Vargas, S.A. is a family-owned pharmaceutical manufacturer based in Caracas, Venezuela, founded in 1955. The company specializes in producing a wide array of medications, catering to healthcare providers, pharmacies, and consumers. With a commitment to quality and innovation, Laboratorios Vargas has established a robust production facility that adheres to Good Manufacturing Practices, ensuring the reliability of their products. The company offers various pharmaceutical forms, including liquids, solids, and semi-solids, and has a significant capacity for manufacturing and conditioning products for both their own brand and third-party clients. Their operational history reflects a dedication to continuous improvement and adaptation to market needs, positioning them as a notable entity in the Venezuelan pharmaceutical landscape.
15. Neolpharma SA de CV
- Website: neolpharma.com
- Ownership type: Private
- Headquarters: Mexico City, Mexico City, Mexico
- Employee distribution: Mexico 85%, Puerto Rico 13%, Other 1%
- Founded year: 2013
- Headcount: 1001-5000
- LinkedIn: neolpharma-s.a.-de-c.v-
Neolpharma SA de CV is a private pharmaceutical company based in Mexico City, Mexico, founded in 2013. The company specializes in the research, development, production, and distribution of high-quality medications. Neolpharma serves healthcare providers, hospitals, and pharmacies, ensuring access to effective pharmaceutical products. With a workforce of approximately 990 employees, the company operates primarily in Mexico (85%) and Puerto Rico (13%). Neolpharma is committed to quality and sustainability, adhering to Good Manufacturing Practices (BPF) and maintaining a robust quality assurance framework. Their product portfolio includes 198 registered medications across various therapeutic classes, such as neurociences, oncology, and antibiotics. Neolpharma also emphasizes corporate social responsibility, engaging in community support and educational initiatives. Their facilities are equipped for comprehensive manufacturing processes, including technology transfer assistance and stability analysis, further solidifying their role in the pharmaceutical industry.
16. Bharat Biotech
- Website: bharatbiotech.com
- Ownership type: Venture Capital
- Headquarters: Hyderabad, Telangana, India
- Employee distribution: India 99%
- Latest funding: Other (Grant), $14.1M, June 2020
- Founded year: 1996
- Headcount: 1001-5000
- LinkedIn: bharat-biotechil
Bharat Biotech International Limited, based in Hyderabad, Telangana, India, is a biotechnology company that specializes in the development and manufacturing of vaccines and biotherapeutics. Established in 1996 by Dr. Krishna M. Ella and Mrs. Suchitra Ella, the company has a mission to provide innovative solutions to combat infectious diseases, particularly in developing countries. Bharat Biotech has made significant strides in research and development, owning over 220 patents and delivering more than 9 billion vaccine doses globally. Their manufacturing facilities are compliant with international standards, including approvals from the USFDA, KFDA, and WHO. The company has developed a range of vaccines, including those for rotavirus, typhoid, and COVID-19, showcasing their commitment to addressing urgent health challenges. Bharat Biotech's focus on R&D and their partnerships with global health organizations highlight their role in improving health outcomes worldwide. In June 2020, they received a grant of $14.1 million, which underscores their ongoing efforts to innovate and expand their capabilities in vaccine production.
17. Kedrion Biopharma
- Website: kedrion.com
- Ownership type: Private Equity
- Headquarters: Fort Lee, New Jersey, United States (USA)
- Employee distribution: Italy 49%, United States (USA) 27%, United Kingdom (UK) 14%, Other 11%
- Latest funding: September 2022
- Founded year: 2001
- Headcount: 1001-5000
- LinkedIn: kedrion-biopharma
Kedrion Biopharma is a biopharmaceutical company founded in 2001, headquartered in Fort Lee, New Jersey. The company specializes in the production and distribution of plasma-derived therapies aimed at treating rare and debilitating conditions, such as coagulation disorders and immunodeficiencies. With a workforce of over 2,200 employees, Kedrion operates multiple production plants across Europe and North America, and it has established plasma collection centers in the United States and the Czech Republic. The company has expanded its capabilities through strategic acquisitions, including Bio Products Laboratory, enhancing its portfolio of therapies. Kedrion is dedicated to ensuring access to essential medical products for healthcare providers and national health systems, emphasizing quality and safety in all its operations. Their commitment to social responsibility and transparency further underscores their role in the pharmaceutical industry.
18. Laboratório Cristália
- Website: cristalia.com.br
- Ownership type: Private
- Headquarters: Itapira, Sao Paulo, Brazil
- Employee distribution: Brazil 100%
- Founded year: 1972
- Headcount: 5001-10000
- LinkedIn: laboratoriocristalia
Laboratório Cristália, based in Itapira, São Paulo, Brazil, is a private pharmaceutical and biotechnology company that has been operational since 1972. The company specializes in the development and manufacturing of a wide array of medications, with a strong emphasis on anesthetics and biological products. Cristália serves hospitals, healthcare providers, and patients, focusing on innovative therapies and enhancing healthcare outcomes through rigorous research and development. With a workforce of approximately 3,778 employees, the company operates a comprehensive industrial complex that includes facilities for pharmaceutical, farmoquímica, and biotechnological production. Cristália is recognized for its commitment to innovation, holding 129 patents and actively engaging in the development of new medications. The company exports its products to over 30 countries, showcasing its international reach and relevance in the global pharmaceutical market.
19. Neopharma
- Website: neopharma.com
- Ownership type: Private
- Headquarters: Abu Dhabi, Abu Dhabi, United Arab Emirates (UAE)
- Employee distribution: United Arab Emirates 87%, Saudi Arabia 4%, Other 9%
- Founded year: 2003
- Headcount: 5001-10000
- LinkedIn: neopharmaglobal
Neopharma, established in 2003 and headquartered in Abu Dhabi, UAE, is a pharmaceutical manufacturer dedicated to producing high-quality medications. The company specializes in both branded and generic formulations, as well as active pharmaceutical ingredients (APIs). With a workforce of approximately 388 employees and a global presence supported by ten manufacturing facilities across three continents, Neopharma serves healthcare providers in over 50 countries. Their product portfolio includes more than 100 molecules across various therapeutic areas, such as anti-infectives, cardiology, and oncology. Neopharma emphasizes innovation, with a robust research and development program aimed at advancing treatment options for life-threatening diseases. The company has formed strategic partnerships and joint ventures with notable pharmaceutical firms, enhancing its capabilities in manufacturing and marketing biopharmaceuticals. Neopharma's commitment to quality is reflected in its adherence to stringent regulatory standards and its focus on delivering affordable healthcare solutions.
20. Pharco Corporation
- Website: pharco.org
- Ownership type: Private
- Headquarters: Alexandria, Scotland, United Kingdom (UK)
- Employee distribution: Egypt 95%, Saudi Arabia 3%, Other 2%
- Latest funding: IPO, May 2006
- Founded year: 1987
- Headcount: 5001-10000
- LinkedIn: pharco-corporation
Pharco Corporation, established in 1987, is a prominent pharmaceutical manufacturer based in Alexandria, Egypt. The company specializes in the development, production, and marketing of a wide array of pharmaceutical products, including generics and branded generics. Pharco is particularly noted for its efforts in combating Hepatitis C, having reportedly cured over 4 million patients through its innovative treatments. With a workforce of approximately 8,000 employees, Pharco operates multiple facilities and has a significant production capacity, producing around 2.5 million packs daily. The company exports its products to more than 50 countries, showcasing its international reach. Pharco's commitment to affordable healthcare is reflected in its mission to provide safe and effective pharmaceutical products accessible to all patients. The company also emphasizes research and development, ensuring that it remains at the forefront of pharmaceutical innovation in the region.
21. MSD Sharp & Dohme GmbH
- Website: msd.de
- Ownership type: Private
- Headquarters: Amt Neuhaus, Lower Saxony, Germany
- Founded year: 2001
- Headcount: 1001-5000
- LinkedIn: msd-sharp-%26-dohme-gmbh
MSD Sharp & Dohme GmbH, a subsidiary of Merck & Co., Inc., is a pharmaceutical company based in Amt Neuhaus, Lower Saxony, Germany. Founded in 2001, the company specializes in the research, development, and manufacturing of innovative medications and vaccines. MSD focuses on critical therapeutic areas, including oncology, infectious diseases, and vaccines, striving to enhance health outcomes for patients worldwide. The company serves healthcare providers, hospitals, and patients, emphasizing accessibility and the importance of effective healthcare solutions. MSD is also involved in clinical research and has a robust pipeline of products aimed at addressing various health conditions. With a workforce of approximately 2,438 employees, MSD is recognized as one of the prominent pharmaceutical manufacturers in Germany, contributing significantly to the healthcare landscape.
22. Hilton Pharma Limited
- Website: hiltonpharma.com
- Ownership type: Private
- Headquarters: Karachi, Sindh, Pakistan
- Employee distribution: Pakistan 97%, Other 3%
- Founded year: 1976
- Headcount: 1001-5000
- LinkedIn: hilton-pharma-limited
Hilton Pharma Limited, based in Karachi, Sindh, Pakistan, is a private pharmaceutical company founded in 1976. With a workforce of approximately 1,914 employees, the company has carved out a significant niche in the pharmaceutical industry. Hilton Pharma specializes in the manufacturing and marketing of a wide range of products, including prescription drugs, biotech products, veterinary health care solutions, and consumer health products. The company emphasizes quality and innovation, ensuring that its manufacturing processes comply with stringent regulatory standards. Hilton Pharma markets products under license from various well-known research-based pharmaceutical companies, alongside its own branded generic specialties. The company has also made strides in international markets, showcasing its products at exhibitions and expanding its export capabilities. Hilton Pharma is recognized for its commitment to corporate social responsibility, actively participating in health care initiatives and educational support programs.
Pharmaceutical Manufacturing Insights: Key Companies in Puerto Rico
Company | Headquarter | Size | Founded | Ownership |
---|---|---|---|---|
Intas Pharmaceuticals | Ahmedabad, Gujarat, India | 10001+ | 2000 | Private Equity |
Laboratorios Bagó | General Pacheco, Buenos Aires, Argentina | 5001-10000 | 1934 | Private |
Eskayef Pharmaceuticals Ltd. | Dhaka, Dhaka, Bangladesh | 5001-10000 | 1990 | Private |
Polpharma | Poland | 1001-5000 | 1935 | Private |
Mundipharma | Cambridge, England, United Kingdom (UK) | 1001-5000 | 1952 | Corporate |
PharmEvo Private Limited | Karachi, Sindh, Pakistan | 1001-5000 | 1999 | Private |
Opsonin Pharma Ltd | Dhaka, Dhaka, Bangladesh | 5001-10000 | 1956 | Private |
Douglas Pharmaceuticals | Auckland, Auckland, New Zealand | 501-1000 | 1967 | Family Owned |
Amoun Pharmaceutical Company | Al Waili Al Kabir Sharq, Cairo Governorate, Egypt | 1001-5000 | 1998 | Corporate |
Cadila Pharmaceuticals Limited | Ahmedabad, Gujarat, India | 5001-10000 | 1951 | Corporate |
Ems | Hortolândia, Sao Paulo, Brazil | 1001-5000 | 1964 | Private |
Pharmasyntez Group of Companies | Russia | 1001-5000 | 1997 | Private |
Martin Dow Limited | Karachi, Sindh, Pakistan | 1001-5000 | 1995 | Private |
Laboratorios Vargas, S.A. | Caracas, Capital, Venezuela | 1001-5000 | 1955 | Family Owned |
Neolpharma SA de CV | Mexico City, Mexico City, Mexico | 1001-5000 | 2013 | Private |
Bharat Biotech | Hyderabad, Telangana, India | 1001-5000 | 1996 | Venture Capital |
Kedrion Biopharma | Fort Lee, New Jersey, United States (USA) | 1001-5000 | 2001 | Private Equity |
Laboratório Cristália | Itapira, Sao Paulo, Brazil | 5001-10000 | 1972 | Private |
Neopharma | Abu Dhabi, Abu Dhabi, United Arab Emirates (UAE) | 5001-10000 | 2003 | Private |
Pharco Corporation | Alexandria, Scotland, United Kingdom (UK) | 5001-10000 | 1987 | Private |
MSD Sharp & Dohme GmbH | Amt Neuhaus, Lower Saxony, Germany | 1001-5000 | 2001 | Private |
Hilton Pharma Limited | Karachi, Sindh, Pakistan | 1001-5000 | 1976 | Private |
Want to Find More Pharmaceutical Manufacturing Companies?
If you want to find more companies that offer innovative therapies, generics, and specialized medical solutions you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.With Inven you'll also get to know the company's:- Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
- Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
- Financials: How do these companies perform financially? What are their revenues and profit margins?
...and a lot more!
Trusted by 700+ companies

















